Work

Improvements in Hypereosinophilic Syndrome (HES) Symptoms and Impacts with Benralizumab: Mixed-Methods Analysis of the NATRON In-Trial Interview Sub-Study

Year: 2026

Type: article

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2025.12.743

Authors: Calvin Ho, Princess Ogbogu, Piotr Łacwik, Piotr Kuna, Amy Klion, Marta Chełmińska, Peter Bressler, Florence Roufosse, Anna Kovalszki, Lila Bahadori, Julie Bailey, Jennifer Hill, Eyra Pérez, Irma González

Institutions: AstraZeneca (United States), Rainbow Babies & Children's Hospital, Jan Kochanowski University, Medical University of Lodz, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Gdańsk Medical University, Université Libre de Bruxelles, Erasmus Hospital, University of Michigan, IQVIA (United States)

Language: English

Topic: Eosinophilic Disorders and Syndromes

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7128512014

FWCI:

Cites:

Cited by:

Related to: